Square Pharmaceuticals PLC. announcements
313 Dhaka Stock Exchange announcements for Square Pharmaceuticals PLC. (SQURPHARMA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2013 (16).
- Mr. Dabiruddin Ahmed, one of the Sponsors of the Company, has further reported that he has completed his transfer of 5,0
Mr. Dabiruddin Ahmed, one of the Sponsors of the Company, has further reported that he has completed his transfer of 5,00,000 shares of the Company to his son Mr. Bashir Ahmed by way of gift outside the trading system of the Exchange as announced earlier.
- Mr. Dabiruddin Ahmed, one of the Sponsors of the Company, has expressed his intention to transfer 5,00,000 shares out of
Mr. Dabiruddin Ahmed, one of the Sponsors of the Company, has expressed his intention to transfer 5,00,000 shares out of his total holding of 97,86,522 shares of the Company to his son Mr. Bashir Ahmed by way of gift outside the trading system of the Exchange within 30 working days from the date of issuance of approval letter by DSE.
- (H/Y): As per un-audited half yearly accounts as on 30.09.2013 (April'13 to Sep'13), the Company has reported consolidat
(H/Y): As per un-audited half yearly accounts as on 30.09.2013 (April'13 to Sep'13), the Company has reported consolidated net profit after tax (excluding non-controlling interests) of Tk. 2,515.49 million with consolidated EPS of Tk. 5.22 as against Tk. 2,050.76 million and Tk. 4.25 respectively for the same period of the previous year. Whereas consolidated net profit after tax (excluding non-controlling interests) was Tk. 1,183.65 million with consolidated EPS of Tk. 2.46 for the period of 3 months (July'13 to Sep'13) ended on 30.09.2013 as against Tk. 1,067.78 million and Tk. 2.22 respectively for the same period of the previous year.
- The Company has informed that it has credited the bonus shares for the year ended on March 31, 2013 to the respective sh
The Company has informed that it has credited the bonus shares for the year ended on March 31, 2013 to the respective shareholders' BO Accounts on September 30, 2013.
- The Company has informed that a total of 1,12,09,730 shares of Late Mrs. Jahanara Begum, a Sponsor shareholder of Square
The Company has informed that a total of 1,12,09,730 shares of Late Mrs. Jahanara Begum, a Sponsor shareholder of Square Pharmaceuticals Ltd., has been transmitted to her legal heirs (husband, son and daughters) in the following manner according to the Succession Certificate issued by the Honorable Court: (1) 28,02,432 shares to Dr. Kazi Harunar Rashid, (2) 42,03,648 shares to Kazi Iqbal Harun, (3) 21,01,825 shares to Mrs. Nilufar Ferdous and (4) 21,01,825 shares to Mrs. Nargis Ferdous.
- Normal trading of the shares of the Company will resume on 27.08.2013 after record date.
Normal trading of the shares of the Company will resume on 27.08.2013 after record date.
- Trading of the shares of the Company will remain suspended on record date i.e., 26.08.2013.
Trading of the shares of the Company will remain suspended on record date i.e., 26.08.2013.
- Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 21.08.2013 to 25.08.2013. Trading of the shares of the Company will remain suspended on record date i.e., 26.08.2013.
- (Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th June 2013 (Apr'13 to June'13), the Company
(Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th June 2013 (Apr'13 to June'13), the Company has reported consolidated profit after tax (excluding non-controlling interest) of Tk. 1,331.84 million with consolidated basic EPS of Tk. 3.59 as against Tk. 982.98 million and Tk. 2.65 respectively for the same period of the previous year. However, considering proposed bonus share @ 30% for the year 2013, consolidated restated basic EPS will be Tk. 2.76 as on 30.06.13 and Tk. 2.04 as on 30.06.12.
- There will be no price limit on the trading of the shares of the Company today (22.07.2013) following its corporate decl
There will be no price limit on the trading of the shares of the Company today (22.07.2013) following its corporate declaration.
- The Board of Directors has recommended cash dividend @ 25% (i.e. Tk. 2.50 per share of Tk. 10.00 each) and stock dividen
The Board of Directors has recommended cash dividend @ 25% (i.e. Tk. 2.50 per share of Tk. 10.00 each) and stock dividend @ 30% for the year ended on March 31, 2013. The Board has also decided to increase the Authorized Capital of the Company from Tk. 500.00 crore to Tk. 1,000.00 crore subject to approval of the shareholders. Date of AGM: 25.09.2013, Time: 11:00 AM, Venue: Factory premises, Kaliakoir, Gazipur. Record Date: 26.08.2013. The Company has also reported NAV of Tk. 18,844.75 million, EPS of Tk. 9.01 and NOCFPS of Tk. 12.41 for the year ended on March 31, 2013.
- As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will
As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on July 21, 2013 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on March 31, 2013.
- Mr. Samuel S Chowdhury, one of the Sponsors/Directors of the Company, has further reported that he has completed his buy
Mr. Samuel S Chowdhury, one of the Sponsors/Directors of the Company, has further reported that he has completed his buy of 16,100 shares of the Company at prevailing market price through Stock Exchange as announced earlier.
- Q3 Earnings 2012-13
As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2012 (Oct'12 to Dec'12), the Company has reported consolidated profit after tax (excluding non controlling interest) of Tk. 1,194.34 million with consolidated EPS of Tk. 3.22 as against Tk. 945.52 million and Tk. 2.55 respectively for the same period of the previous year. Whereas consolidated profit after tax (excluding non controlling interest) was Tk. 3,245.10 million with consolidated EPS of Tk. 8.75 for the period of nine months (Apr'12 to Dec'12) ended on 31.12.2012 as against Tk. 2,968.64 million and Tk. 8.01 respectively for the same period of the previous year.
- (Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2012 (Oct'12 to Dec'12), the Compa
(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2012 (Oct'12 to Dec'12), the Company has reported consolidated profit after tax (excluding non controlling interest) of Tk. 1,194.34 million with consolidated EPS of Tk. 3.22 as against Tk. 945.52 million and Tk. 2.55 respectively for the same period of the previous year. Whereas consolidated profit after tax (excluding non controlling interest) was Tk. 3,245.10 million with consolidated EPS of Tk. 8.75 for the period of nine months (Apr'12 to Dec'12) ended on 31.12.2012 as against Tk. 2,968.64 million and Tk. 8.01 respectively for the same period of the previous year.
- Mr. Samuel S Chowdhury, one of the Sponsors/Directors of the Company, has expressed his intention to buy 16,100 shares o
Mr. Samuel S Chowdhury, one of the Sponsors/Directors of the Company, has expressed his intention to buy 16,100 shares of the Company at prevailing market price through Stock Exchange within January 31, 2013.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.